Literature DB >> 26973262

Influence of Cognitive Behavioral Therapy on Mood and Quality of Life After Stent Implantation in Young and Middle-Aged Patients With Coronary Heart Disease.

Jianfeng Lv1, Xingmei Zhang, Shulin Ou, Shanshan Gu, Zhizhou Su, Shifei Tong, Bo Liu, Zhiyuan Song, Luxiang Chi.   

Abstract

Cognitive behavioral therapy (CBT), established only a few decades ago, is widely used by clinical psychologists. This study aimed to investigate the effects of CBT on mental status and quality of life (QOL) after percutaneous coronary intervention (PCI) in young and middle-aged patients with coronary heart disease (CHD). Seventy-five anxiety/depression patients (mean age, 52.2 ± 6.2 years, including 8 individuals < 45 years old) with CHD treated with PCI were randomly divided into a CBT group (n = 38) and control group (n = 37). The CBT group received 8 weeks of CBT in addition to the routine postoperative treatment that was also administered to control patients. The 17-item Hamilton Depression Rating Scale (HAM-D17), Hamilton anxiety scale (HAM-A), and Coronary Revascularization Outcome Questionnaire (CROQ-PTCA-POST, Chinese version) were administered before, 3 days, and 8 weeks after intervention. HAM-D17 and HAM-A scores were decreased after treatment, but were more substantially reduced in patients that underwent CBT than those in the control group (11.7 ± 4.5 versus 15.1 ± 3.9, P = 0.001 and 10.6 ± 3.4 versus 16.5 ± 4.6, P = 0.003, respectively). QOL was improved in both groups, but overall satisfaction was higher in the CBT group compared with control patients (89.3 ± 5.2 versus 77.8 ± 9.5, P < 0.05). CBT can relieve depression and anxiety after PCI in young and middle-aged patients with CHD. CBT can improve patient QOL.

Entities:  

Mesh:

Year:  2016        PMID: 26973262     DOI: 10.1536/ihj.15-259

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  8 in total

1.  Treatment of Anxiety in Patients With Coronary Heart Disease: A Systematic Review.

Authors:  Julia M Farquhar; Gregory L Stonerock; James A Blumenthal
Journal:  Psychosomatics       Date:  2018-03-27       Impact factor: 2.386

Review 2.  Depression, anxiety, and quality of life after percuataneous coronary interventions.

Authors:  Rajiv Kumar Saini; Suprakash Chaudhury; Navreet Singh; D S Chadha; Rajneesh Kapoor
Journal:  Ind Psychiatry J       Date:  2022-05-20

Review 3.  Psychological and pharmacological interventions for depression in patients with coronary artery disease.

Authors:  Phillip J Tully; Ser Yee Ang; Emily Jl Lee; Eileen Bendig; Natalie Bauereiß; Jürgen Bengel; Harald Baumeister
Journal:  Cochrane Database Syst Rev       Date:  2021-12-15

4.  Effects of transitional health management on adherence and prognosis in elderly patients with acute myocardial infarction in percutaneous coronary intervention: A cluster randomized controlled trial.

Authors:  Qing Wu; Dandan Zhang; Qi Zhao; Lin Liu; Zhisong He; Yan Chen; Hui Huang; Yunyin Hou; Xiaofang Yang; Jie Gu
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

5.  The Effect of Two Methods of Relaxation and Prayer Therapy on Anxiety and Hope in Patients with Coronary Artery Disease: A Quasi-Experimental Study.

Authors:  Soudabeh Sadeghimoghaddam; Mousa Alavi; Tayebeh Mehrabi; AmirHosein Bankpoor-Fard
Journal:  Iran J Nurs Midwifery Res       Date:  2019 Mar-Apr

Review 6.  Psychiatric and Psychological Interventions for Depression in Patients With Heart Disease: A Scoping Review.

Authors:  Juliana Zambrano; Christopher M Celano; James L Januzzi; Christina N Massey; Wei-Jean Chung; Rachel A Millstein; Jeff C Huffman
Journal:  J Am Heart Assoc       Date:  2020-11-07       Impact factor: 5.501

7.  Postoperative Cognitive Behavioral Intervention in Patients with Coronary Heart Disease Based on the Effect of Nursing Process Reengineering.

Authors:  Ying Xiong; Yan Liu; Jianying Cui
Journal:  Biomed Res Int       Date:  2022-09-17       Impact factor: 3.246

8.  The Effect of Cognitive Behavioral Therapy on Depression, Anxiety, and Stress in Patients With COVID-19: A Randomized Controlled Trial.

Authors:  Jinzhi Li; Xiuchuan Li; Jie Jiang; Xuexue Xu; Jing Wu; Yuanyuan Xu; Xin Lin; John Hall; Huashan Xu; Jincheng Xu; Xiaoyue Xu
Journal:  Front Psychiatry       Date:  2020-10-30       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.